DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Weetman AP, Shepherdley CA, Mansell P. et al.
Thyroid over-expression of type 1 and 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment.
Eur J Endocrinol 2003;
149: 443-447
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.